Updates on Chemotherapy, Immunotherapy, and Targeted Agents, Including Side Effects, Contraindications, Indications, and Naturopathic Side Effect Management with Shauna & Tim Birdsall, ND, FABNO
Worth 1 CE (of which 1 is pharm)
Over the past year, the FDA has approved and expanded the indications for many new drugs related to cancer treatment, including chemotherapy agents, immunotherapy drugs and target agents. The drugs continue to become more sophisticated as well as individualized towards specific mutations. From a naturopathic oncology perspective, understanding the mechanism of action, anticipating the more common and less frequent adverse effects and having a solid understanding of how these drugs are metabolized is essential to co-managing patients on these pharmaceuticals. In addition, being proactive with patients with naturopathic interventions for side effect management, as well as determining drug-herb-nutrient interactions and contra-indications is key in providing optimal integrative oncology care. Given that the nature of oncology is that the conventional treatment landscape is ever-evolving, a strategy will be discussed to provide participants the tools needed to evaluate new conventional oncology drugs and determine how and if their naturopathic oncology interventions for side effect management and naturopathic co-treatment need to be modified and/or updated.
Learning Objectives
Define a strategy for naturopathic co-management of patients undergoing
chemotherapy, immunotherapy, and targeted agents
Understand the pharmacology of new oncologic agents including indications and side effects
Recognize potential herb-drug-nutrient interactions and contra-indications
Identify common naturopathic oncology interventions for to side effect management
Worth 1 CE (of which 1 is pharm)
Over the past year, the FDA has approved and expanded the indications for many new drugs related to cancer treatment, including chemotherapy agents, immunotherapy drugs and target agents. The drugs continue to become more sophisticated as well as individualized towards specific mutations. From a naturopathic oncology perspective, understanding the mechanism of action, anticipating the more common and less frequent adverse effects and having a solid understanding of how these drugs are metabolized is essential to co-managing patients on these pharmaceuticals. In addition, being proactive with patients with naturopathic interventions for side effect management, as well as determining drug-herb-nutrient interactions and contra-indications is key in providing optimal integrative oncology care. Given that the nature of oncology is that the conventional treatment landscape is ever-evolving, a strategy will be discussed to provide participants the tools needed to evaluate new conventional oncology drugs and determine how and if their naturopathic oncology interventions for side effect management and naturopathic co-treatment need to be modified and/or updated.
Learning Objectives
Define a strategy for naturopathic co-management of patients undergoing
chemotherapy, immunotherapy, and targeted agents
Understand the pharmacology of new oncologic agents including indications and side effects
Recognize potential herb-drug-nutrient interactions and contra-indications
Identify common naturopathic oncology interventions for to side effect management
Worth 1 CE (of which 1 is pharm)
Over the past year, the FDA has approved and expanded the indications for many new drugs related to cancer treatment, including chemotherapy agents, immunotherapy drugs and target agents. The drugs continue to become more sophisticated as well as individualized towards specific mutations. From a naturopathic oncology perspective, understanding the mechanism of action, anticipating the more common and less frequent adverse effects and having a solid understanding of how these drugs are metabolized is essential to co-managing patients on these pharmaceuticals. In addition, being proactive with patients with naturopathic interventions for side effect management, as well as determining drug-herb-nutrient interactions and contra-indications is key in providing optimal integrative oncology care. Given that the nature of oncology is that the conventional treatment landscape is ever-evolving, a strategy will be discussed to provide participants the tools needed to evaluate new conventional oncology drugs and determine how and if their naturopathic oncology interventions for side effect management and naturopathic co-treatment need to be modified and/or updated.
Learning Objectives
Define a strategy for naturopathic co-management of patients undergoing
chemotherapy, immunotherapy, and targeted agents
Understand the pharmacology of new oncologic agents including indications and side effects
Recognize potential herb-drug-nutrient interactions and contra-indications
Identify common naturopathic oncology interventions for to side effect management